Skip to main content
. Author manuscript; available in PMC: 2023 Dec 4.
Published in final edited form as: Lancet Digit Health. 2023 Dec;5(12):e882–e894. doi: 10.1016/S2589-7500(23)00179-6

Table 3:

Epilepsy-related outcomes and health-care utilisation in the 2 years after an initial diagnosis

Median (IQR) Mean p value
Boston Children’s Hospital IBM MarketScan Boston Children’s Hospital IBM MarketScan
Presence of a diagnosis of status epilepticus* 0 (0–0) 0 (0–0) 0·14 (0·35) 0·25 (0·43) <0·0001
Number of inpatient admissions for all causes 0 (0–0) 0 (0–0) 1·57 (7·84) 0·91 (2·07) <0·0001
Number of inpatient admissions for seizures 0 (0–0) 0 (0–0) 0·37 (1·25) 0·34 (0·84) 0·013
General utilisation; number of distinct days with ICD code 7 (3–15) 17 (14–37) 12·82 (19·89) 25·78 (37·78) <0·0001
Seizure-related utilisation; number of distinct days with seizure-related ICD codes 2 (0–6) 3 (2–10) 4·13 (5·97) 6·40 (14·02) <0·0001
Number of ASM classes (mean of those receiving at least 1 ASM) 1 (0–2) 1 (0–2) 1·36 (1·79) 1·41 (1·71) 0·17
Number of neurology notes during epilepsy-related ICD visit 3 (1–8) NA 6·61 (10·90) NA NA
Number of seizure-related imaging and procedures 0 (0–1) 0 (0–1) 0·84 (2·35) 0·86 (2·41) >0·25
Composite score (meeting any of the criteria defined in panel) 1 (0–1) 1 (0–1) 0·57 (0·50) 0·63 (0·48) <0·001

Data are median (IQR) or mean (SD). ICD=International Classification of Diseases. ASM=antiseizure medication. NA=not available.

*

1=present, 0=absent; mean represents proportion of patients with diagnosis.